Ticagrelor Increases SIRT1 and HES1 mRNA Levels in Peripheral Blood Cells from Patients with Stable Coronary Artery Disease and Chronic Obstructive Pulmonary Disease

Ticagrelor is a powerful P2Y(12) inhibitor with pleiotropic effects in the cardiovascular system. Consistently, we have reported that in patients with stable coronary artery disease (CAD) and concomitant chronic obstructive pulmonary disease (COPD) who underwent percutaneous coronary intervention (P...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Int J Mol Sci
Main Authors: Aquila, Giorgio, Vieceli Dalla Sega, Francesco, Marracino, Luisa, Pavasini, Rita, Cardelli, Laura Sofia, Piredda, Anna, Scoccia, Alessandra, Martino, Valeria, Fortini, Francesca, Bononi, Ilaria, Martini, Fernanda, Manfrini, Marco, Pannuti, Antonio, Ferrari, Roberto, Rizzo, Paola, Campo, Gianluca
Formato: Artigo
Idioma:Inglês
Publicado em: MDPI 2020
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7084534/
https://ncbi.nlm.nih.gov/pubmed/32106619
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms21051576
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados